ArticleFrontiers in pharmacology2022

Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells.

Maria Krchniakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.